Nutriband (NTRB)
(Real Time Quote from BATS)
$4.53 USD
+0.06 (1.34%)
Updated Sep 16, 2024 02:24 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
NTRB 4.53 +0.06(1.34%)
Will NTRB be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for NTRB based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for NTRB
Nutriband reports Q2 EPS (15c) vs. (11c) last year
Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25
NTRB Stock Earnings: Nutriband Reported Results for Q1 2024
Nutriband provides development update for Aversa Fentanyl